http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105566305-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04 |
filingDate | 2012-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105566305-B |
titleOfInvention | The polymorph and its preparation method and application of 4- (substituted anilinic) quinazoline derivant xylenesulfonate |
abstract | The polymorph and its preparation method and application of 4 (substituted anilinic) quinazoline derivant xylenesulfonates, the present invention relates to the polymorphs as 4 amine xylenesulfonate (compound I) of tyrosine kinase inhibitor N (4 (3 fluorine benzyloxy) 3 chlorphenyls) 6 (5 ((2 (methyl sulfoxide base) ethylamino) methyl) 2 furyls) quinazoline.Specifically, the present invention relates to crystal form A, B, C and D of compound I.The invention further relates to the preparation methods of the polymorph of compound I, including its pharmaceutical composition and their pharmaceutical applications.The polymorph of the compounds of this invention I is effective tyrosine kinase inhibitor. |
priorityDate | 2012-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 608.